Why the study?
Partly due to its focus on simplicity, the widely used HEART score has limitations, prompting modifications to circumvent them.
Does the HEART score accurately predict short-term MACE in patients with acute chest pain compared to other risk scores?
Does the HEART score accurately predict short-term MACE in patients with acute chest pain compared to other risk scores?
The HEART score is a strong, evolving tool for acute chest pain risk stratification that outperforms TIMI and GRACE scores for predicting short-term MACE.
Answers are grounded in this paper and cite their sources.
Supports HEART score preference over TIMI/GRACE for short-term MACE prediction; extends validation literature but leaves open prospective trials.
The history, electrocardiogram, age, risk factors, and troponin (HEART) score is currently a widely used tool for acute chest pain risk stratification. Relatively soon after its inception in 2008, a number of validation studies on the HEART score showed it to be superior to Thrombolysis in Myocardial Infarction (TIMI) and Global Registry of Acute Coronary Events (GRACE) scores and at least as accurate to other existing scores for predicting short-term major adverse cardiovascular events (MACEs). However, partly due to its focus on simplicity, the HEART score has some limitations. In this article we review how the HEART score has evolved and taken on various modifications to circumvent some of its limitations. We also highlight the strength of the HEART score in comparison with other risk stratification tools and the current guidelines.
No takes yet. Share an insight, caveat, or question.
Aung et al. (2022) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: